Analyst Price Target is $88.71
▲ +49.28% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Trupanion in the last 3 months. The average price target is $88.71, with a high forecast of $120.00 and a low forecast of $69.00. The average price target represents a 49.28% upside from the last price of $59.43.
Current Consensus is
The current consensus among 3 investment analysts is to buy stock in Trupanion. This rating has held steady since July 2021, when it changed from a Hold consensus rating.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.